Search

Your search keyword '"Verkarre, Virginie"' showing total 663 results

Search Constraints

Start Over You searched for: Author "Verkarre, Virginie" Remove constraint Author: "Verkarre, Virginie"
663 results on '"Verkarre, Virginie"'

Search Results

102. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease--associated inflammation and lymphomagenesis

106. Germline MET pathogenic variants in papillary renal cell carcinomas type I: specific phenotype in French population and novel germline pathogenic variant MET c.3389T>C, p.(Leu1130Ser)

107. Overexpression of miR‐483‐5p is confined to metastases and linked to high circulating levels in patients with metastatic pheochromocytoma/paraganglioma

109. Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade

110. Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s

112. Comprehensive study of nine novel cases of TFEB‐amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression.

114. Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey

115. The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival

116. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma

117. Familial Focal Congenital Hyperinsulinism

122. Functional Imaging of the Pancreas: The Role of [ 18 F]Fluoro- L -DOPA PET in the Diagnosis of Hyperinsulinism of Infancy

128. Congenital Hyperinsulinism: Pancreatic [18F]Fluoro-l-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography and Immunohistochemistry Study of DOPA Decarboxylase and Insulin Secretion

131. Using Contrast-Enhanced Ultrasound in Addition to Cross-Sectional Imaging for Indeterminate Renal Cysts May Lead to Overclassification in Bosniak III Category: A Case-Control Study.

134. iPSC-Derived Embryoid Bodies as Models of c-Met-Mutated Hereditary Papillary Renal Cell Carcinoma

135. Abstract 3688: iPSC-derived cancer organoids recapitulate genomic and phenotypic alterations of c-Met-mutated hereditary kidney cancer

136. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth

137. Congenital hyperinsulinism: current trends in diagnosis and therapy

141. Unbalanced Expression of 11p15 Imprinted Genes in Focal Forms of Congenital Hyperinsulinism: Association with a Reduction to Homozygosity of a Mutation in ABCC8 or KCNJ11

143. Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1(+) Tim-3(+) CD8(+) T Cells

144. Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma

145. iPSC-derived Cancer Organoids Recapitulate Genomic and Phenotypic Alterations of c-met-mutated Hereditary Kidney Cancer

146. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study

147. Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial

148. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease

149. MP28-17 NON-TYPE 1 PAPILLARY RENAL CELL CARCINOMA IS ASSOCIATED WITH A WORST ONCOLOGICAL OUTCOME IN PATIENTS TREATED SURGICALLY

150. LBA29 COMPLEMENT ACTIVATION ORCHESTRATED BY CANCER CELLS AND C1Q-PRODUCING TUMOR ASSOCIATED MACROPHAGES HAS A DELETERIOUS IMPACT ON PATIENT’S PROGNOSIS IN CLEAR CELL RENAL CELL CANCER.

Catalog

Books, media, physical & digital resources